1 asset in Fallopian Tube Disorder

Therapeutic assets addressing Fallopian Tube Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Mirvetuximab Soravtansine Fallopian Tube Disorder	University of Alabama at Birmingham	P2	CCC (53)